A large number of methods for the conversion of aldehydes to esters have been reported in the literature over the last thirty years. 2 Baeyer-Villiger oxidation of ketones and aldehydes using peracid is frequently chosen due to its easy manipulation and high productivity. 3 However, the reaction of acyclic acetal derived from a ketone (a ketal) with peracid is known to be sluggish and to provide the orthocarbonate as the result of dual Baeyer-Villiger oxidation. 4 Several methods of direct oxidation of acetal to esters with oxidizing agents such as, peracetic acid, 5 chromium trioxide, 6 ozone, 7 tert-butylhydroperoxide, 8 PDC/ t-BuOOH, 9 NBS, 10 peroxymonosulfuric acid, 11 dimethyldioxirane, 12 or hydrogen peroxide 13 have been reported. Recently, we reported a facile procedure for the conversion of aldehydes to the corresponding esters via acetal formation from aldehydes and subsequent oxidation by m-CPBA with BF 3 ·OEt 2 .
14 Based on our recent reports, we wish to utilize this methodology for the synthesis of biologically important compounds.
Alibendol, 2-hydroxy-N-(2-hydroxyethyl)-3-methoxy-5-(2-propenyl)benzamide is known as antispasmodic, chleretic, and cholekinetic active pharmaceutical ingredient (API) which is useful in treatment of dyspepsia due to biliary insufficiency, alimentary intolerance, urticaria, pruritus, migraine, and constipation of hepatic origin.
15
To date, only a few patents for the synthesis of Alibendol have been reported. 15 We speculated that the preparation of methyl 3-methyoxy-2-(2-propenyloxy)benzoate (3) would be undoubtedly achieved since the one-pot oxidation of salicyl aldehyde to methyl salicylate has been successfully carried out by m-CPBA with BF 3 ·OEt 2 .
14c The preparation of methyl 3-methyoxy-2-(2-propenyloxy)benzoate (3) has been tried by two routes (Scheme 1). o-Vanillin was treated with trimethyl orthoformate and Amberlyst ® 15 (wet) to provide in situ dimethyl acetal intermediate, and the subsequent oxidation by m-CPBA with BF 3 ·OEt 2 in chloroform afforded methyl 2-hydroxy-3-methoxybenzoate (1) in 83% yield. The hydroxyl group of methyl 2-hydroxy-3-methoxybenzoate (1) was quantitatively allylated with allyl bromide and K 2 CO 3 to give methyl 3-methyoxy-2-(2-propenyloxy)benzoate (3). On the other hand, o-vanillin was allylated in same manner as above mentioned method. Then, O-allyl o-vanillin (2) was converted to methyl 3-methyoxy-2-(2-propenyloxy)benzoate (3) in 93% yield by the same in situ procedure. The Claisen rearrangement of allyl vinyl ether has been well established. 17 Various reaction solvents such as DMF, TFA, pxylene, and toluene have been used for the Claisen rearrangement of methyl 3-methyoxy-2-(2-propenyloxy)-benzoate (3). However, most reactions were sluggish and not completed even longer reaction time. Thus, we carried out the Claisen rearrangement in neat reaction condition as in the case of the precedent procedure.
17c The last step of synthesis of Alibendol was straight forward formation of the amide by the reaction of methyl ester 4 with ethanolamine at 120 o C. In summary, we accomplished a facile synthesis of Alibendol from o-vanillin via in situ formation of dimethyl acetal intermediate and the subsequent oxidation by m-CPBA with BF3·OEt2, and the para Claisen rearrangement in five steps and 68% (through o-vanillin to 2) or 61% (through o-vanillin to 1) overall yield.
Experimental Section
General. All reactions were carried out under an inert atmosphere of argon. Chloroform was freshly distilled from phosphorus pentoxide prior to use. Liquid reagents and solvents used were reagent grade and purified prior to use, if necessary, by methods reported in the literature. 18 Analytical thin layer chromatography was performed on pre-coated Merck silica gel 60 F254 TLC plate. Flash column chromatography was performed using Merck silica gel 60 (230-400 mesh) under positive pressure of air according to the procedure of Still. 19 Uncorrected melting points were determined with a Gallenkamp melting point apparatus.
1 H NMR and 13 C NMR spectral data were obtained on a Varian Gemini 300 (300 MHz) spectrometer. Infrared spectra were recorded using a BioRad FT-IR spectrophotometer with internal calibration. Mass spectra were recorded on a Varian WS 1200 mass spectrometer.
General procedure for the preparation of methyl ester 1 and 3. To a solution of aldehyde (10 mmol) in dried CHCl 3 (30 mL) were added Amberlyst ® 15 (wet) ion exchange resin (0.5 g) and triethyl orthoformate (4.4 mL, 40 mmol) under the argon atmosphere at ambient temperature. The mixture was stirred at reflux condition. After being stirred for 3 h, a small amount of BF 3 ·OEt 2 (0.38 mL, 3 mmol) and m-CPBA (72%, 2.40 g, 10 mmol) were added. The resulting reaction mixture was stirred for 1 h at ambient temperature. The reaction mixture was diluted with ethyl acetate (15 mL) and quenched with 0.5 N NaOH solution (30 mL). The resulting solution was treated with 0.5 N HCl solution (30 mL). The aqueous layer was extracted with ethyl acetate (15 mL × 3) and the combined organic layer was dried over anhydrous sodium sulfate. The desired methyl esters were purified by SiO 2 gel flash column chromatography. 
